Mobile medical app guidance closer to delay with passage of Senate bill

The U.S. Senate passed the Food and Drug Administration Safety and Innovation Act last week, including the provision that would radically slow the completion of their mobile medical app guidance. A version now is under consideration in the House, with no date set yet for a vote. Pundits indicate it is likely to pass, while industry reactions are largely con on the measure, as it likely will delay the guidance until 2013 at the earliest. Article

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.